Evaluating the effect of VersaWrap tendon protector on functional outcomes in operative tendon repairs
- PMID: 39737387
- PMCID: PMC11683011
- DOI: 10.3389/fsurg.2024.1447515
Evaluating the effect of VersaWrap tendon protector on functional outcomes in operative tendon repairs
Abstract
Background: Tendon repairs often result in adhesion formation which can cause persisting functional deficits. Close proximity of healing tissues increases friction during tendon excursion, often leading to tendon tethering postoperatively. Despite continued improvements in techniques for tendon repairs, there is currently no consensus on the most effective modality to reduce adhesion formation. The VersaWrap Tendon Protector is a bioresorbable hydrogel that is FDA-cleared for use in tendon repair by separating healing tendons from surrounding tissues and improving tendon gliding. We conducted a study to assess the efficacy of VersaWrap in improving clinical outcomes related to adhesions and tethering in tendon repairs involving the hand.
Materials & methods: Age, sex, injury type, mechanism of injury, visual analogue scale (VAS) pain scores, active and passive range of motion (ROM), percent return to normal function, and patient-reported outcomes forms (QuickDASH) were collected at baseline and routine follow up visits. Functional outcomes were classified according to Strickland and Glogovac grading system.
Results: 90 patients were included, with an average age of 39.8 years and a 44% female gender. The most common mechanism of injury was sharp laceration, and the majority of repairs involved the extensor mechanism (58.8% extensor, 35.3% flexor, 5.8% both). At a mean follow-up of 4.6 months, the mean active and passive ROM was 88.8% and 94.3%, respectively. Mean percent return of function was 87.7%. Good or Excellent functional outcomes were achieved in 92.3% of patients - 70.5% Excellent, 21.8% Good, 6.4% Fair, 1.3% Poor. The average QuickDASH score was 30.7, and the average final VAS pain score was 1.3.
Conclusions: Tendon repairs and tenolysis procedures often result in reduced functionality due to impeded tendon gliding, and there is currently no consensus on optimal treatment to prevent tethering to surrounding tissues. The VersaWrap Tendon Protector creates a gelatinous layer between the tendon and surrounding soft tissue to improve gliding resistance, thereby limiting tendon sheath adhesions. Our data suggests that VersaWrap may be a useful adjunct in preventing tendon tethering adhesion post-repair.
Keywords: VersaWrap; bioresorbable hydrogel sheet; operative tendon repairs; tendon; tendon protector.
© 2024 Adu, Harder, Cox, Baum, Hernandez and MacKay.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Similar articles
-
Primary pulley enlargement in zone 2 by incision and repair with an extensor retinaculum graft.J Hand Surg Am. 2010 May;35(5):785-90. doi: 10.1016/j.jhsa.2010.01.032. Epub 2010 Apr 7. J Hand Surg Am. 2010. PMID: 20378274
-
Systemic EP4 Inhibition Increases Adhesion Formation in a Murine Model of Flexor Tendon Repair.PLoS One. 2015 Aug 27;10(8):e0136351. doi: 10.1371/journal.pone.0136351. eCollection 2015. PLoS One. 2015. PMID: 26312751 Free PMC article.
-
Use of a bioresorbable polylactide sheet (OrthoWrap® Bioresorbable sheet) on tendon healing after extensor tendon repair: a controlled clinical trial.BMC Musculoskelet Disord. 2025 Jan 2;26(1):1. doi: 10.1186/s12891-024-08241-z. BMC Musculoskelet Disord. 2025. PMID: 39743570 Free PMC article. Clinical Trial.
-
Clinical outcomes associated with flexor tendon repair.Hand Clin. 2005 May;21(2):199-210. doi: 10.1016/j.hcl.2004.11.005. Hand Clin. 2005. PMID: 15882599 Review.
-
[Tenolysis of the flexor tendons in the hand].Orthopade. 2015 Oct;44(10):767-76. doi: 10.1007/s00132-015-3157-1. Orthopade. 2015. PMID: 26310324 Review. German.
Cited by
-
Bioresorbable hyaluronic acid alginate hydrogel use in total ankle arthroplasty to control post-operative scarring.J Surg Case Rep. 2025 Jul 14;2025(7):rjaf533. doi: 10.1093/jscr/rjaf533. eCollection 2025 Jul. J Surg Case Rep. 2025. PMID: 40661728 Free PMC article.
-
Urological Applications of Novel Hyaluronic Acid/Alginate Gel to Protect Nerves: A Single-Surgeon Experience.Cureus. 2025 Feb 17;17(2):e79156. doi: 10.7759/cureus.79156. eCollection 2025 Feb. Cureus. 2025. PMID: 39963292 Free PMC article.
-
Peripheral Nerve Protection Strategies: Recent Advances and Potential Clinical Applications.J Funct Biomater. 2025 Apr 24;16(5):153. doi: 10.3390/jfb16050153. J Funct Biomater. 2025. PMID: 40422818 Free PMC article. Review.
References
-
- Kane SF, Olewinski LH, Tamminga KS. Management of chronic tendon injuries. Am Fam Physician. (2019) 100(3):147–57. - PubMed
LinkOut - more resources
Full Text Sources